Activation of CB1R-Dependent <i>PGC</i>-<i>1</i> Is Involved in the Improved Mitochondrial Biogenesis Induced by Electroacupuncture Pretreatment

Sisi Sun,Tao Jiang,Na Duan,Meiyan Wu,Chaoying Yan,Yan Li,Min Cai,Qiang Wang
DOI: https://doi.org/10.1089/rej.2020.2315
2021-01-01
Rejuvenation Research
Abstract:Electroacupuncture (EA) pretreatment induces cerebral ischemic tolerance; however, the mechanism remains poorly understood. This study aimed to determine the participation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha)-mediated mitochondrial biogenesis in the neuroprotection of EA and whether cannabinoid receptor 1 (CB1R) is involved in this mechanism. At 2 hours after EA pretreatment, adult male C57BL/6j mice were subjected to 60-minute right middle cerebral artery occlusion (MCAO). Mitochondrial function, the level of mitochondrial biogenesis-related proteins (nuclear transcription factor 1, NRF1; mitochondrial transcription factor A, TFAM), and mitochondrial DNA (mtDNA) were measured. A small interfering RNA (siRNA) targeting PGC-1 alpha and the CB1R antagonists AM251 and SR141716A were given to the animals before EA pretreatment, and mitochondrial function and biogenesis were examined after MCAO. EA ameliorated the mitochondrial function, upregulated the NRF1 and TFAM expression, and increased the mtDNA levels and the volume and number of mitochondria. EA pretreatment increased the expression of PGC-1 alpha, whereas the PGC-1 alpha siRNA and CB1R antagonists reversed the improved neuroprotection and increased mitochondrial biogenesis induced by EA. Our results indicated that EA pretreatment protects the mitochondria and promotes mitochondrial biogenesis by activating CB1R-dependent PGC-1 alpha, which provides a novel mechanism for EA pretreatment-induced ischemic tolerance.
What problem does this paper attempt to address?